Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3491Neoplasms 2738Prostatic Neoplasms 1580Colorectal Neoplasms 1243Lung Neoplasms 1184Motor Activity 763Head and Neck Neoplasms 619Pancreatic Neoplasms 600Colonic Neoplasms 586Uterine Cervical Neoplasms 563Carcinoma, Non-Small-Cell Lung 559Carcinoma, Hepatocellular 556Rectal Neoplasms 514Stomach Neoplasms 490Brain Neoplasms 435Anxiety Disorders 400Ovarian Neoplasms 396Pain 375Esophageal Neoplasms 347Neoplasm Metastasis 340Polycystic Ovary Syndrome 339Fatigue 323Urinary Bladder Neoplasms 314Precursor Cell Lymphoblastic Leukemia-Lymphoma 303Melanoma 298Depression 285Multiple Myeloma 281Endometrial Neoplasms 262Lymphoma 257Hematologic Neoplasms 250

Interventions

Specimen Handling 1Relaxation Therapy 1Physical Therapy Modalities 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × OTHER × Resectable Lung Non-Small Cell Carcinoma × Clear all
NCT07584239 2026-05-26

Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS Trial

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
30 enrolled

Resectable Lung Non-Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡